Thilini Peramuna, Gwendolyn E Wood, Ziwei Hu, Karen L Wendt, Laarni Kendra T Aguila, Caroline M Kim, Adam S Duerfeldt, Robert H Cichewicz
{"title":"具有抗阴道毛滴虫和生殖器支原体活性的半合成含四甲酸酯的真菌代谢物","authors":"Thilini Peramuna, Gwendolyn E Wood, Ziwei Hu, Karen L Wendt, Laarni Kendra T Aguila, Caroline M Kim, Adam S Duerfeldt, Robert H Cichewicz","doi":"10.1021/acsmedchemlett.4c00386","DOIUrl":null,"url":null,"abstract":"<p><p>Tetramic acid-containing natural products are well known for their promising biological activity against various diseases. In our previous study, we reported fungal-derived tetramic acid-containing natural products with activity against <i>Trichomonas vaginalis</i>. Here, we demonstrate that <i>Mycoplasma genitalium</i> is also highly susceptible to this chemotype and we uncovered the initial structure activity relationships on disparate tetramate chemotypes in phomasetin (<b>6</b>) and pyrrolocin A (<b>10</b>). Further, <b>6</b> and <b>10</b> were modified using \"click\" chemistry to re-engineer bioactivity. Compounds <b>6</b> and <b>10</b> hold promise as a pipeline-diversifying chemotype for promising leads against <i>T</i>. <i>vaginalis</i> and <i>M</i>. <i>genitalium</i>.</p>","PeriodicalId":20,"journal":{"name":"ACS Medicinal Chemistry Letters","volume":"15 11","pages":"1933-1939"},"PeriodicalIF":3.5000,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571018/pdf/","citationCount":"0","resultStr":"{\"title\":\"Semisynthetic Tetramate-Containing Fungal Metabolites with Activity against <i>Trichomonas vaginalis</i> and <i>Mycoplasma genitalium</i>.\",\"authors\":\"Thilini Peramuna, Gwendolyn E Wood, Ziwei Hu, Karen L Wendt, Laarni Kendra T Aguila, Caroline M Kim, Adam S Duerfeldt, Robert H Cichewicz\",\"doi\":\"10.1021/acsmedchemlett.4c00386\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Tetramic acid-containing natural products are well known for their promising biological activity against various diseases. In our previous study, we reported fungal-derived tetramic acid-containing natural products with activity against <i>Trichomonas vaginalis</i>. Here, we demonstrate that <i>Mycoplasma genitalium</i> is also highly susceptible to this chemotype and we uncovered the initial structure activity relationships on disparate tetramate chemotypes in phomasetin (<b>6</b>) and pyrrolocin A (<b>10</b>). Further, <b>6</b> and <b>10</b> were modified using \\\"click\\\" chemistry to re-engineer bioactivity. Compounds <b>6</b> and <b>10</b> hold promise as a pipeline-diversifying chemotype for promising leads against <i>T</i>. <i>vaginalis</i> and <i>M</i>. <i>genitalium</i>.</p>\",\"PeriodicalId\":20,\"journal\":{\"name\":\"ACS Medicinal Chemistry Letters\",\"volume\":\"15 11\",\"pages\":\"1933-1939\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2024-10-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571018/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Medicinal Chemistry Letters\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1021/acsmedchemlett.4c00386\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/11/14 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Medicinal Chemistry Letters","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acsmedchemlett.4c00386","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/14 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
Semisynthetic Tetramate-Containing Fungal Metabolites with Activity against Trichomonas vaginalis and Mycoplasma genitalium.
Tetramic acid-containing natural products are well known for their promising biological activity against various diseases. In our previous study, we reported fungal-derived tetramic acid-containing natural products with activity against Trichomonas vaginalis. Here, we demonstrate that Mycoplasma genitalium is also highly susceptible to this chemotype and we uncovered the initial structure activity relationships on disparate tetramate chemotypes in phomasetin (6) and pyrrolocin A (10). Further, 6 and 10 were modified using "click" chemistry to re-engineer bioactivity. Compounds 6 and 10 hold promise as a pipeline-diversifying chemotype for promising leads against T. vaginalis and M. genitalium.
期刊介绍:
ACS Medicinal Chemistry Letters is interested in receiving manuscripts that discuss various aspects of medicinal chemistry. The journal will publish studies that pertain to a broad range of subject matter, including compound design and optimization, biological evaluation, drug delivery, imaging agents, and pharmacology of both small and large bioactive molecules. Specific areas include but are not limited to:
Identification, synthesis, and optimization of lead biologically active molecules and drugs (small molecules and biologics)
Biological characterization of new molecular entities in the context of drug discovery
Computational, cheminformatics, and structural studies for the identification or SAR analysis of bioactive molecules, ligands and their targets, etc.
Novel and improved methodologies, including radiation biochemistry, with broad application to medicinal chemistry
Discovery technologies for biologically active molecules from both synthetic and natural (plant and other) sources
Pharmacokinetic/pharmacodynamic studies that address mechanisms underlying drug disposition and response
Pharmacogenetic and pharmacogenomic studies used to enhance drug design and the translation of medicinal chemistry into the clinic
Mechanistic drug metabolism and regulation of metabolic enzyme gene expression
Chemistry patents relevant to the medicinal chemistry field.